Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The options have an exercise price of $14.78 per share, which is equal to the closing price of Akebia’s common stock on the grant date. Each stock option vests over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remaining 75% of shares vesting quarterly thereafter, in each case, subject to the new employee’s continued service with the company. Each stock option has a ten-year term and is subject to the terms and conditions of the company’s 2016 Inducement Award Program and a stock option agreement covering the grant.
About Akebia Therapeutics
John Garabo, 617-844-6130
Director, Corporate Communications